Vestal Point Capital »

Astrazeneca Plc Ord shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Astrazeneca Plc Ord (AZN) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Astrazeneca Plc Ord

Tip: Access up to 7 years of quarterly data

All positions including Astrazeneca Plc Ord held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astrazeneca Plc Ord by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $20M 100k 197.22

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Astrazeneca Plc Ord

Investor AB
Vanguard Capital Management
Capital Research and Management Company - Division 3
Capital World Investors
Legal & General Group
Bank of America Corporation
Vanguard Asset Management
PRIMECAP Management Company
Franklin Resources
Amundi
Vanguard Fiduciary Trust
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Deutsche Bank Aktiengesellschaft
Henderson Group
Aviva

View all funds holding Astrazeneca Plc Ord